Abstract:Adipose tissue can be divided anatomically, histologically, and functionally into two major entities white and brown adipose tissues (WAT and BAT, respectively). WAT is the primary energy depot, storing most of the bioavailable triacylglycerol molecules of the body, whereas BAT is designed for dissipating energy in the form of heat, a process also known as non-shivering thermogenesis as a defense against a cold environment. Importantly, BAT-dependent energy dissipation directly correlates with cardiometabolic health and has been postulated as an intriguing target for anti-obesity therapies. In general, adipose tissue (AT) lipid content is defined by lipid uptake and lipogenesis on one side, and, on the other side, it is defined by the breakdown of lipids and the release of fatty acids by lipolysis. The equilibrium between lipogenesis and lipolysis is important for adipocyte and general metabolic homeostasis. Overloading adipocytes with lipids causes cell stress, leading to the recruitment of immune cells and adipose tissue inflammation, which can affect the whole organism (metaflammation). The most important consequence of energy and lipid overload is obesity and associated pathophysiologies, including insulin resistance, type 2 diabetes, and cardiovascular disease. The fate of lipolysis products (fatty acids and glycerol) largely differs between AT: WAT releases fatty acids into the blood to deliver energy to other tissues (e.g., muscle). Activation of BAT, instead, liberates fatty acids that are used within brown adipocyte mitochondria for thermogenesis. The enzymes involved in lipolysis are tightly regulated by the second messenger cyclic adenosine monophosphate (cAMP), which is activated or inhibited by G protein-coupled receptors (GPCRs) that interact with heterotrimeric G proteins (G proteins). Thus, GPCRs are the upstream regulators of the equilibrium between lipogenesis and lipolysis. Moreover, GPCRs are of special pharmacological interest because about one third of the approved drugs target GPCRs. Here, we will discuss the effects of some of most studied as well as "novel" GPCRs and their ligands. We will review different facets of in vitro, ex vivo, and in vivo studies, obtained with both pharmacological and genetic approaches. Finally, we will report some possible therapeutic strategies to treat obesity employing GPCRs as primary target.

Leveraging GPCR signaling in thermogenic fat to counteract metabolic diseases

GPCR in Adipose Tissue Function—Focus on Lipolysis

GPCR-mediated regulation of beige adipocyte formation: Implications for obesity and metabolic health

Molecular and cellular regulation of thermogenic fat

Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis

GPR180 is a component of TGFβ signalling that promotes thermogenic adipocyte function and mediates the metabolic effects of the adipocyte-secreted factor CTHRC1

89-OR: GPSM1 Regulates ER Ca2+-Myosin II Axis and Promotes Adipocyte Browning and Metabolic Health

Molecular Regulation of Thermogenic Mechanisms in Beige Adipocytes

Opioid Growth Factor Receptor Promotes Adipose Tissue Thermogenesis Via Enhancing Lipid Oxidation

Recruitment of Thermogenic Fat: Trigger of Fat Burning

Elucidation of the roles of brown and brite fat genes: GPR120 is a modulator of brown adipose tissue function

Metabolic responses of light and taste receptors – unexpected actions of GPCRs in adipocytes

T Cell Factor 7 (TCF7)/TCF1 Feedback Controls Osteocalcin Signaling in Brown Adipocytes Independent of the Wnt/β-Catenin Pathway

Unraveling the complexity of thermogenic remodeling of white fat reveals potential antiobesity therapies

Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism

RGCC Promotes Adipocyte Thermogenesis by Modulating Pgc1α Expression

GPR120: a Critical Role in Adipogenesis, Inflammation, and Energy Metabolism in Adipose Tissue

Cell-cell crosstalk between fat cells and immune cells

FGF2 disruption enhances thermogenesis in brown and beige fat to protect against obesity and hepatic steatosis

Combined α- and β-adrenergic receptor activation triggers thermogenesis by the futile creatine cycle

Constitutively active receptor ADGRA3 signaling induces adipose thermogenesis